Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
53.34 USD | -1.89% | +0.75% | -15.06% |
05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
05-01 | TD Cowen Adjusts Price Target on Incyte to $80 From $88 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.06% | 12.21B | |
-2.35% | 89.33B | |
+4.08% | 41.19B | |
-14.63% | 31.87B | |
+53.68% | 24.52B | |
-15.00% | 15.68B | |
-8.63% | 12.34B | |
-40.39% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation
- Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call